|
YMI024 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- Novartis Pharmaceuticals1
Indications
- Heart Disease1
- Coronary Artery Disease1
Fairhope, Alabama1 trial
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Eastern Shore Research Institute
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.